0 Folders
0 Documents
0 Folders
0 Documents
0 Folders
2 Documents

Sacyr sells three P3 assets in Colombia to Actis for $1.6 billion

  • The scope of the deal includes Pamplona-Cúcuta Highway, Autopista al Mar 1 and Rumichaca Pasto Highway and will likely be completed in the second half of 2025.
  • Sacyr will remain active in Colombia, operating three other P3 projects.

Sacyr has signed an agreement with an entity controlled by Actis Long Life Infrastructure Fund 2 to sell its entire stake in three operational P3 assets in Colombia. The assets in question are Unión Vial Río Pamplonita (Pamplona-Cúcuta Highway), Desarrollo Vial al Mar (Autopista al Mar 1) and Concesionaria Vial Unión del Sur (Rumichaca Pasto Highway). 

The value of the transaction amounts to a total of $1.6 billion, including debt and equity

This transaction underscores the value of Sacyr's assets, with the amount of the sale being 12% above the valuation provided in the Investor Day 2024.

The completion of the transaction is subject to the fulfilment of certain customary conditions precedent set out for this type of operation, and it is expected to take place during the second half of 2025.

Accounting Impact and on cash flow statement

This transaction will have a very positive impact on the Company’s Cash Flow Statement due to the cash inflow of $318 million resulting from this divestment. 

In accordance with the accounting treatment established by international accounting standards (IFRIC XII) for concession companies classified as financial assets, where equity increases during the construction phase, this transaction will generate a negative accounting impact for Sacyr of approximately €65 million. However, this could be positively offset by what is stated in the sale and purchase agreement, under which Sacyr is entitled to receive variable amounts (earn-outs) valued at approximately $70 million, with a positive accounting and cash impact depending on the success of different claims currently in process.

Fast-tracking growth 

This divestment, in line with Sacyr's standard asset rotation strategy, strengthens the balance sheet to accelerate the company's growth plan, which expects to triple its equity and asset valuation by 2033. 

In addition, it aligns with the company’s goal of balancing the geographic distribution of its current project portfolio.

Activities in Colombia

Following this divestment, Sacyr will maintain its activities in Colombia, operating three assets: Puerta de Hierro Highway (in operation), Buenaventura-Loboguerrero-Buga Road Corridor and the Restoration of the Degraded Canal del Dique Ecosystems, with the latter two in the development phase.

  • P3 Projects

Desarrollamos uno de los mayores complejos sanitarios de Italia

El proyecto concesional del Parque de la Salud de Turín incluirá un nuevo hospital con 1.400 camas y un campus universitario de 5.000 m2

El proyecto concesional Parco della Salute, della Ricerca e dell’Innovazione di Torino (Parque de la Salud, la Investigación y la Innovación de Turín) será un complejo multifuncional que incluirá un nuevo hospital y un campus universitario. La inversión prevista supera los 517 millones de euros y el plazo de construcción es de cinco años.

El proyecto adjudicado por Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, organismo público de la Región del Piamonte, tiene una duración total de 30 años, será ejecutado por el consorcio concesionario formado por SIS (90%) y ABP Nocivelli (10%). El contrato incluye el diseño, construcción, financiación, concesión y mantenimiento del hospital.

La concesión abarca el mantenimiento de los elementos estructurales y arquitectónicos, las instalaciones mecánicas y eléctricas y la gestión de las áreas comerciales.

Centro de referencia

Este proyecto se convertirá en un centro de referencia médica y científica en Italia y su estratégica ubicación en el sur de Turín dará servicio a alrededor de 300.000 personas. 

El nuevo complejo contará con cuatro bloques conectados entre sí, adonde se trasladarán las actuales instalaciones sanitarias de la Molinette, el CTO y el Hospital Sant'Anna, que actualmente conforman la Ciudad de la Salud. Acogerá investigaciones clínicas, preclínicas y traslacionales; además de ofrecer un espacio para las actividades docentes (cursos de grado en medicina y profesiones de la salud).

1.400

camas

5.000

m2

campus universitario

517 M€

inversión

  • Hospitals

Características

300 
 

Las principales características de la construcción del proyecto son:

  • 1.040 camas
  • 19 quirófanos
  • 175.000 m2 de hospital + 64.000 m2 de parking subterráneo
  • 5.000 m2 áreas de formación
  • 1.525 m2 áreas comerciales
0 Folders
2 Documents

Centro de referencia

Este proyecto se convertirá en un centro de referencia médica y científica en Italia y su estratégica ubicación en el sur de Turín dará servicio a alrededor de 300.000 personas. 

El nuevo complejo contará con cuatro bloques conectados entre sí, adonde se trasladarán las actuales instalaciones sanitarias de la Molinette, el CTO y el Hospital Sant'Anna, que actualmente conforman la Ciudad de la Salud. Acogerá investigaciones clínicas, preclínicas y traslacionales; además de ofrecer un espacio para las actividades docentes (cursos de grado en medicina y profesiones de la salud).

1.400

camas

5.000

m2

campus universitario

517 M€

inversión

  • Corporate

Call notice: Annual General Meeting 2025

Sacyr's Board of Directors has resolved to convene an Ordinary General Shareholders' Meeting, to be held on June 11th , 2025, at 12:00 noon, on first call or, if the necessary quorum is not reached, on second call, on the following day June 12th , 2025.

The General Meeting is scheduled to be held on second call, i.e. on June 12 th , 2025, at 12:00.

The event will be livestreamed.

Featured projects

Annual General Meeting

The 2025 Annual General Meeting will be held on June 11th, 2025, at 12:00 h, on first call or, if the necessary quorum is not reached, on second 
call, at the same place and time, on the following June 12th 2025.

The 2025 AGM is expected to be held on the second call and will be livestreamed.

This website uses its own and third-party cookies to improve the user experience and analyze their behavior in order to improve the service offered.
You can consult additional information about the cookies installed on our Cookies policy.

Cookie Settings

Cookie declaration

TECHNIQUES

These cookies are exempt from compliance with article 22.2 of the LSSI in accordance with the recommendations indicated by the European authority on privacy and cookies. In accordance with the above and although configuration, acceptance or denial is not possible, the editor of this website offers information about them in an exercise of transparency with the user.

  • Name: LFR_Session_STATE_*, Provider: Liferay, Purpose: Manages the session as a registered user , Expiration: Session, Type: HTTP

  • Name: GUEST_LANGUAGE_ID, Provider: Liferay, Purpose: Determines the language with which you access , to show the same in the next session, Expiration: 1 year, Type: HTTP

  • Name: ANONYMOUS_USER_ID, Provider: Liferay, Purpose: Manages the session as an unregistered user , Expiration: 1 year, Type: HTTP

  • Name: COOKIE_SUPPORT, Provider: Liferay, Purpose: Identifies that the use of cookies for the operation of the portal, Expiration: 1 year, Type: HTTP

  • Name: JSessionID, Provider: Liferay, Purpose: Manages login and indicates who is using the site, Expiry: Session, Type: HTTP

  • Name: SACYRGDPR, Supplier: Sacyr, Purpose: Used to manage the cookie policy , Expiration: Session, Type: HTTP